← Back to Glenmark Pharmaceuticals Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

GLENMARKPharmaceuticals

Glenmark Pharmaceuticals Ltd — Financial Ratios & Key Metrics

₹2131.70

+0.82%

P/E Ratio21.78xIndustry: 31.77x

ROE15.79%Return on equity

ROCE19.40%Return on capital

Debt/Equity0.13Low debt

💎

Valuation & Profitability

P/E Ratio

21.78x

Industry Average P/E

31.77x

Dividend Yield

0.13%

Market Cap

₹54.77K (Cr)

Sales Growth 5Y

4.60%

Profit Growth 5Y

11.77%

EPS Growth 5Y

11.77%

OPM 5Y Avg

16.68%

📉

Price Returns

1 Month

+2.67%

3 Months

+1.19%

6 Months

+28.35%

1 Year

+27.02%

52W Low

₹1336

Current

₹2132

52W High

₹2298

83% of 52-week range — Near highs

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹2058

▲ Price above SMA 50 — Bullish

SMA 200

₹1977

▲ Long-term uptrend

Volume Signal

136% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Glenmark Pharmaceuticals Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.